ÿþ<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"> <head> <meta http-equiv=Content-Type content="text/html; charset=unicode"> <meta name=ProgId content=Word.Document> <meta name=Generator content="Microsoft Word 12"> <meta name=Originator content="Microsoft Word 12"> <link rel=File-List href="Relay%20Cochrane!%20-%20Volume%205_files/filelist.xml"> <link rel=Edit-Time-Data href="Relay%20Cochrane!%20-%20Volume%205_files/editdata.mso"> <!--[if !mso]> <style> v\:* {behavior:url(#default#VML);} o\:* {behavior:url(#default#VML);} w\:* {behavior:url(#default#VML);} .shape {behavior:url(#default#VML);} </style> <![endif]--> <title>Cochrane</title> <!--[if gte mso 9]><xml> <o:DocumentProperties> <o:Author>Loaner</o:Author> <o:Template>NormalEmail</o:Template> <o:Revision>1</o:Revision> <o:TotalTime>1</o:TotalTime> <o:Created>2008-09-05T13:16:00Z</o:Created> <o:Pages>1</o:Pages> <o:Words>2209</o:Words> <o:Characters>12592</o:Characters> <o:Lines>104</o:Lines> <o:Paragraphs>29</o:Paragraphs> <o:CharactersWithSpaces>14772</o:CharactersWithSpaces> <o:Version>12.00</o:Version> </o:DocumentProperties> </xml><![endif]--> <link rel=themeData href="Relay%20Cochrane!%20-%20Volume%205_files/themedata.thmx"> <link rel=colorSchemeMapping href="Relay%20Cochrane!%20-%20Volume%205_files/colorschememapping.xml"> <!--[if gte mso 9]><xml> <w:WordDocument> <w:Zoom>0</w:Zoom> <w:TrackMoves/> <w:TrackFormatting/> <w:ValidateAgainstSchemas/> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF/> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:DoNotExpandShiftReturn/> <w:BreakWrappedTables/> <w:SplitPgBreakAndParaMark/> <w:DontVertAlignCellWithSp/> <w:DontBreakConstrainedForcedTables/> <w:DontVertAlignInTxbx/> <w:Word11KerningPairs/> <w:CachedColBalance/> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> <m:mathPr> <m:mathFont m:val="Cambria Math"/> <m:brkBin m:val="before"/> <m:brkBinSub m:val="&#45;-"/> <m:smallFrac m:val="off"/> <m:dispDef/> <m:lMargin m:val="0"/> <m:rMargin m:val="0"/> <m:defJc m:val="centerGroup"/> <m:wrapIndent m:val="1440"/> <m:intLim m:val="subSup"/> <m:naryLim m:val="undOvr"/> </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true" DefSemiHidden="true" DefQFormat="false" DefPriority="99" LatentStyleCount="267"> <w:LsdException Locked="false" Priority="0" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Normal"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 1"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 2"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 3"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/> <w:LsdException Locked="false" Priority="39" Name="toc 1"/> <w:LsdException Locked="false" Priority="39" Name="toc 2"/> <w:LsdException Locked="false" Priority="39" Name="toc 3"/> <w:LsdException Locked="false" Priority="39" Name="toc 4"/> <w:LsdException Locked="false" Priority="39" Name="toc 5"/> <w:LsdException Locked="false" Priority="39" Name="toc 6"/> <w:LsdException Locked="false" Priority="39" Name="toc 7"/> <w:LsdException Locked="false" Priority="39" Name="toc 8"/> <w:LsdException Locked="false" Priority="39" Name="toc 9"/> <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/> <w:LsdException Locked="false" Priority="10" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Title"/> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/> <w:LsdException Locked="false" Priority="11" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/> <w:LsdException Locked="false" Priority="22" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Strong"/> <w:LsdException Locked="false" Priority="20" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/> <w:LsdException Locked="false" Priority="59" SemiHidden="false" UnhideWhenUsed="false" Name="Table Grid"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/> <w:LsdException Locked="false" Priority="1" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 1"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 1"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 1"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/> <w:LsdException Locked="false" Priority="34" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/> <w:LsdException Locked="false" Priority="29" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Quote"/> <w:LsdException Locked="false" Priority="30" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 1"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 1"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 2"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 2"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 2"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 2"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 2"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 3"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 3"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 3"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 3"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 3"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 4"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 4"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 4"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 4"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 4"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 5"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 5"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 5"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 5"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 5"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 6"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 6"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 6"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 6"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 6"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/> <w:LsdException Locked="false" Priority="19" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/> <w:LsdException Locked="false" Priority="21" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/> <w:LsdException Locked="false" Priority="31" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/> <w:LsdException Locked="false" Priority="32" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/> <w:LsdException Locked="false" Priority="33" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Book Title"/> <w:LsdException Locked="false" Priority="37" Name="Bibliography"/> <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/> </w:LatentStyles> </xml><![endif]--> <style> <!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:1; mso-generic-font-family:roman; mso-font-format:other; mso-font-pitch:variable; mso-font-signature:0 0 0 0 0 0;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1610611985 1073750139 0 0 159 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; color:#333333;} h1 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"Heading 1 Char"; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; mso-pagination:widow-orphan; mso-outline-level:1; font-size:24.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; color:#333333; font-weight:bold;} h2 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"Heading 2 Char"; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; mso-pagination:widow-orphan; mso-outline-level:2; font-size:18.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; color:#333333; font-weight:bold;} h3 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"Heading 3 Char"; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; mso-pagination:widow-orphan; mso-outline-level:3; font-size:13.5pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; color:#333333; font-weight:bold;} a:link, span.MsoHyperlink {mso-style-priority:99; color:black; text-decoration:underline; text-underline:single;} a:visited, span.MsoHyperlinkFollowed {mso-style-noshow:yes; mso-style-priority:99; color:black; text-decoration:underline; text-underline:single;} p {mso-style-priority:99; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; color:#333333;} span.Heading1Char {mso-style-name:"Heading 1 Char"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 1"; mso-ansi-font-size:14.0pt; mso-bidi-font-size:14.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#365F91; mso-themecolor:accent1; mso-themeshade:191; font-weight:bold;} span.Heading2Char {mso-style-name:"Heading 2 Char"; mso-style-noshow:yes; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 2"; mso-ansi-font-size:13.0pt; mso-bidi-font-size:13.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#4F81BD; mso-themecolor:accent1; font-weight:bold;} span.Heading3Char {mso-style-name:"Heading 3 Char"; mso-style-noshow:yes; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 3"; mso-ansi-font-size:12.0pt; mso-bidi-font-size:12.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#4F81BD; mso-themecolor:accent1; font-weight:bold;} p.moreinfo, li.moreinfo, div.moreinfo {mso-style-name:moreinfo; mso-style-unhide:no; margin:0in; margin-bottom:.0001pt; text-align:right; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; color:#333333;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page Section1 {size:8.5in 11.0in; margin:1.0in 1.0in 1.0in 1.0in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.Section1 {page:Section1;} --> </style> <!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";} </style> <![endif]--> </head> <body lang=EN-US link=black vlink=black style='tab-interval:.5in'> <div class=Section1> <p class=MsoNormal style='margin-left:120.0pt;text-indent:-120.0pt;tab-stops: 120.0pt;mso-layout-grid-align:none;text-autospace:none'><b><span style='font-family:"Calibri","sans-serif";mso-bidi-font-family:Calibri; color:black'>From:<span style='mso-tab-count:1'>                              </span></span></b><span style='font-family:"Calibri","sans-serif";mso-bidi-font-family:Calibri; color:black'>Canadian Cochrane Network and Centre [carratoo@uottawa.ca]<o:p></o:p></span></p> <p class=MsoNormal style='margin-left:120.0pt;text-indent:-120.0pt;tab-stops: 120.0pt;mso-layout-grid-align:none;text-autospace:none'><b><span style='font-family:"Calibri","sans-serif";mso-bidi-font-family:Calibri; color:black'>Sent:<span style='mso-tab-count:1'>                               </span></span></b><span style='font-family:"Calibri","sans-serif";mso-bidi-font-family:Calibri; color:black'>Wednesday, August 13, 2008 3:01 PM<o:p></o:p></span></p> <p class=MsoNormal style='margin-left:120.0pt;text-indent:-120.0pt;tab-stops: 120.0pt;mso-layout-grid-align:none;text-autospace:none'><b><span style='font-family:"Calibri","sans-serif";mso-bidi-font-family:Calibri; color:black'>To:<span style='mso-tab-count:1'>                                   </span></span></b><span style='font-family:"Calibri","sans-serif";mso-bidi-font-family:Calibri; color:black'>Lisa McGovern<o:p></o:p></span></p> <p class=MsoNormal style='margin-left:120.0pt;text-indent:-120.0pt;tab-stops: 120.0pt;mso-layout-grid-align:none;text-autospace:none'><b><span style='font-family:"Calibri","sans-serif";mso-bidi-font-family:Calibri; color:black'>Subject:<span style='mso-tab-count:1'>                          </span></span></b><span style='font-family:"Calibri","sans-serif";mso-bidi-font-family:Calibri; color:black'>Relay Cochrane! - Volume 5<o:p></o:p></span></p> <p class=MsoNormal><o:p>&nbsp;</o:p></p> <div style='margin-top:3.75pt;margin-bottom:3.75pt' id=wrapper> <p align=center style='text-align:center'><span style='font-size:8.5pt; color:#111111'>Having trouble reading this newsletter? Click <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/r">here</a> to see it in your browser.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/y">Français</a><o:p></o:p></span></p> <div align=center> <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:6.25in;mso-cellspacing:0in;background:white;mso-yfti-tbllook: 1184;mso-padding-alt:0in 0in 0in 0in'> <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'> <td style='padding:0in 0in 0in 0in'> <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;mso-cellspacing:0in;mso-yfti-tbllook:1184;mso-padding-alt: 0in 0in 0in 0in'> <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> <td colspan=2 valign=top style='padding:0in 0in 0in 0in'> <p class=MsoNormal><span style='mso-fareast-font-family:"Times New Roman"'><img border=0 width=600 height=125 id="_x0000_i1025" src="http://cochrane.cmail4.com/email/481431/cochranecubiclefugitivecom/images/ccnc_banner_e.gif" alt="Canadian Cochrane Network and Centre Newsletter"><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:1'> <td width=437 valign=top style='width:327.75pt;padding:11.25pt 7.5pt 11.25pt 7.5pt' id=leftContent> <p align=right style='text-align:right'><strong><span style='font-size: 7.0pt;font-family:"Arial","sans-serif";color:#34758D'>&lt; Volume 5</span></strong><span style='font-size:7.0pt;font-family:"Arial","sans-serif";color:#34758D'> - <strong><span style='font-family:"Arial","sans-serif"'>August 2008 </span></strong>&gt;<o:p></o:p></span></p> <div style='mso-element:para-border-div;border:none;border-bottom:dotted #FAA21B 1.0pt; mso-border-bottom-alt:dotted #FAA21B .75pt;padding:0in 0in 0in 0in'> <p class=MsoNormal style='margin-top:.3in;mso-outline-level:2;border:none; mso-border-bottom-alt:dotted #FAA21B .75pt;padding:0in;mso-padding-alt: 0in 0in 0in 0in'><b><span style='font-family:"Arial","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#FAA21B;mso-font-kerning: 18.0pt'>In the News<o:p></o:p></span></b></p> </div> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><strong><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>New affiliate</span></strong><b><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'><o:p></o:p></span></b></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>The CCNC is pleased to announce the <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/6">Canadian Partnership Against Cancer Corporation</a> as a new affiliate member. Cochrane will work with CPACC to disseminate Cochrane reviews and build capacity in using systematic reviews in their mandate of developing cancer control strategies.<o:p></o:p></span></p> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><strong><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Balancing the good and bad</span></strong><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family: "Times New Roman";color:#34758D'><o:p></o:p></span></b></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>To make balanced decisions, people need to know both the benefits of a treatment and also the harmful effects. The <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/4">Cochrane Adverse Effects Group</a> promotes the inclusion of adverse effects data in Cochrane reviews and provides guidance on how to do this. Interested in incorporating adverse effects into systematic reviews? Join a new discussion list, whether your interest is in searching, inclusion criteria, quality assessment and/or meta-analysis.<o:p></o:p></span></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>For more details go to <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/j">http://lists.cochrane.org/mailman/listinfo/aemg</a><o:p></o:p></span></p> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><strong><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>ASQUS a question  qualitative syntheses</span></strong><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family: "Times New Roman";color:#34758D'><o:p></o:p></span></b></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Qualitative data, such as the results of focus groups or interviews, can help to explain how treatments are experienced or what the barriers to introducing new practices might be. The Cochrane Qualitative Research Methods Group develops and supports methods to include qualitative results in Cochrane reviews. A new discussion list for sharing methodological developments in qualitative evidence syntheses is now available. If you have a question on qualitative evidence synthesis <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/t">ASQUS</a>! <o:p></o:p></span></p> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><strong><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Cochrane Methods update</span></strong><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family: "Times New Roman";color:#34758D'><o:p></o:p></span></b></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Find out the latest in systematic review methods by reading the annual Cochrane Methods newsletter. Articles by the 11 Cochrane Methods Groups and other authors are now available at <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/i">http://cochrane.org/newslett/MethodsGroups_June2008.pdf</a>. <o:p></o:p></span></p> <div style='mso-element:para-border-div;border:none;border-bottom:dotted #FAA21B 1.0pt; mso-border-bottom-alt:dotted #FAA21B .75pt;padding:0in 0in 0in 0in'> <p class=MsoNormal style='margin-top:.3in;mso-outline-level:2;border:none; mso-border-bottom-alt:dotted #FAA21B .75pt;padding:0in;mso-padding-alt: 0in 0in 0in 0in'><strong><span style='font-family:"Arial","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#FAA21B;mso-font-kerning: 18.0pt'>Cochrane for Practice</span></strong><b><span style='font-family: "Arial","sans-serif";mso-fareast-font-family:"Times New Roman";color:#FAA21B; mso-font-kerning:18.0pt'><o:p></o:p></span></b></p> </div> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><strong><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Therapeutics Initiative Podcasts</span></strong><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family: "Times New Roman";color:#34758D'><o:p></o:p></span></b></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Subscribe to the practical, as well as entertaining, <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/d">podcasts</a> produced by the Therapeutics Initiative. Designed to provide a healthy dose of evidence-based drug therapy information these podcasts also bring a smidgeon (or more sometimes) of healthy skepticism. Discussions include treating hypertension, cholesterol control and smoking cessation with an evidence base such as Cochrane reviews and journal articles.<o:p></o:p></span></p> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><strong><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Specialist Library for ENT&nbsp;and Audiology </span></strong><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family: "Times New Roman";color:#34758D'><o:p></o:p></span></b></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>The <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/1">Specialist Library for ENT&nbsp;and Audiology</a> is a unique resource that provides healthcare professionals with access to the best available evidence in ENT, audiology&nbsp;and thyroid disorders. Searchable by condition, specialty or intervention, this database is complemented by Evidence Updates and an e-newsletter. A product of the National Library for Health in the U.K., the Specialist Library uses transparent and systematic methods to identify content such as Cochrane reviews, and&nbsp;is updated regularly. <o:p></o:p></span></p> <div style='mso-element:para-border-div;border:none;border-bottom:dotted #FAA21B 1.0pt; mso-border-bottom-alt:dotted #FAA21B .75pt;padding:0in 0in 0in 0in'> <p class=MsoNormal style='margin-top:.3in;mso-outline-level:2;border:none; mso-border-bottom-alt:dotted #FAA21B .75pt;padding:0in;mso-padding-alt: 0in 0in 0in 0in'><strong><span style='font-family:"Arial","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#FAA21B;mso-font-kerning: 18.0pt'>Cochrane for Policy</span></strong><b><span style='font-family: "Arial","sans-serif";mso-fareast-font-family:"Times New Roman";color:#FAA21B; mso-font-kerning:18.0pt'><o:p></o:p></span></b></p> </div> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><b><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Reminders improve vaccination rates<o:p></o:p></span></b></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Diseases that are preventable by vaccines still occur due to low rates of immunization. This Cochrane review assessed the effectiveness of various types of patient reminder and recall systems to improve immunization rates. In developed countries, multiple reminders by phone, letter, postcard, or in person from primary care settings increased the number of people vaccinated.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/h">Patient reminder and recall systems to improve immunization rates</a><o:p></o:p></span></p> <div style='mso-element:para-border-div;border:none;border-bottom:dotted #FAA21B 1.0pt; mso-border-bottom-alt:dotted #FAA21B .75pt;padding:0in 0in 0in 0in'> <p class=MsoNormal style='margin-top:.3in;mso-outline-level:2;border:none; mso-border-bottom-alt:dotted #FAA21B .75pt;padding:0in;mso-padding-alt: 0in 0in 0in 0in'><strong><span style='font-family:"Arial","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#FAA21B;mso-font-kerning: 18.0pt'>Cochrane Library Spotlight - Issue 3, 2008</span></strong><b><span style='font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#FAA21B;mso-font-kerning:18.0pt'><o:p></o:p></span></b></p> </div> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><em><b><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Asthma</span></b></em><b><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'><o:p></o:p></span></b></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Salmetrol for chronic asthma: serious adverse events</span></strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'><br> People with asthma who regularly take salmetrol have an increased risk of suffering serious adverse effects. While salmetrol, a long-acting beta2-agonist, helps relieve asthma symptoms for up to 12 hours, a review of clinical trials indicated that patients using the drug for 4-6 months were at risk, especially if they were not taking inhaled corticosteroids.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/k">Regular treatment with salmeterol for chronic asthma: serious adverse events</a><o:p></o:p></span></p> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><em><b><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Muskuloskeletal</span></b></em><b><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'><o:p></o:p></span></b></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Mobilize ankle with care after surgery</span></strong><span style='font-size:9.0pt; font-family:"Arial","sans-serif"'><br> Adults who use a removable splint or cast after surgery for a fractured ankle may have increased mobility and less pain. According to a Cochrane review, there is some evidence that encouraging the patient to use the ankle as early as possible following the realignment of the bones will also accelerate the healing process. However, caution should be used to not damage the surgical wound.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/u">Rehabilitation for ankle fracture in adults</a><o:p></o:p></span></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Orthoses can help foot pain</span></strong><b><span style='font-size:9.0pt; font-family:"Arial","sans-serif"'><br> </span></b><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Foot pain can be disabling and affect a person s quality of life. Wearing custom-made orthoses can relieve foot pain caused by a high arches, arthritis and prominent big toe joints. The reviewers of 11 trials involving 1332 people found that relief from the pain caused by certain conditions was alleviated within three to six months.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/b">Custom-made foot orthoses for the treatment of foot pain</a> <o:p></o:p></span></p> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><em><b><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Diabetes</span></b></em><b><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'><o:p></o:p></span></b></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Watch what you eat and exercise to prevent diabetes</span></strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'><br> Individuals with an increased risk for type 2 diabetes can significantly lower their risk through a combination of diet and exercise. This approach was more effective than the standard recommendation for prevention of the disease and diet-only and exercise-only measures. Type 2 diabetes occurred less in people who followed a regiment of a low-calorie, low-fat and high carbohydrate diet and 150 minutes of intense exercise (cycling or jogging) per week.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/n">Exercise or exercise and diet for preventing type 2 diabetes mellitus</a><o:p></o:p></span></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Dietary advice may not be enough</span></strong><span style='font-size:9.0pt; font-family:"Arial","sans-serif"'><br> People at risk for type 2 diabetes are often advised to follow a certain diet to lower their risk of developing the disease. This Cochrane review only found two relevant trials and concluded that, at this time, there is not enough quality information to be able to say that dietary intervention will lower a person s risk of type 2 diabetes.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/p">Dietary advice for the prevention of type 2 diabetes mellitus in adults</a><o:p></o:p></span></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Long-term insulin has some benefit</span></strong><span style='font-size:9.0pt; font-family:"Arial","sans-serif"'><br> The prospect of long-acting insulin has, in theory, promised better quality of life and a reduction in diabetes-related complications. However, this Cochrane review of long-acting versus intermediate-acting insulin does not show any significant benefit from long-term insulin in overall diabetes control. Long-term insulin was better at reducing nocturnal hypoglycemia, however.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/3">Intermediate acting versus long-acting insulin for type 1 diabetes mellitus</a><o:p></o:p></span></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Culturally sensitive diabetes education improves outcomes</span></strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'><br> Members of ethnic minority groups who live in middle- to high-income countries face barriers such as language and socio-economics in accessing adequate healthcare and health information. Reviewers found that tailoring the education approach about type 2 diabetes to the needs of a specific community helped people to control their blood sugar levels and increased their knowledge of the disease in the short term.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/0">Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority </a><o:p></o:p></span></p> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><em><b><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Women s Health</span></b></em><b><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'><o:p></o:p></span></b></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Caesarean section  no consensus on best technique</span></strong><b><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'><br> </span></b><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Although caesarean deliveries are commonplace, medical practitioners remain divided as to which surgical techniques are best. A Cochrane review of surgical techniques for uterine incision and uterine closure was not able to recommend the most appropriate technique to use. This is due to a lack of information on important health outcomes such as infection, pain and subsequent complications for both mother and baby.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/c">Surgical techniques for uterine incision and uterine closure at the time of caesarean section</a><o:p></o:p></span></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Routine removal of ovaries with hysterectomy not supported</span></strong><b><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'><br> </span></b><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>There is no evidence that removing ovaries at the time of hysterectomy provides a health benefit to women. Ovaries continue to produce hormones after a hysterectomy; however half of all women have their ovaries removed along with the uterus. The reason often cited is that removing the ovaries prevents ovarian cancer but this has not been demonstrated.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/2">Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women</a><o:p></o:p></span></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Techniques for identifying fetal distress</span></strong><span style='font-size:9.0pt; font-family:"Arial","sans-serif"'><br> A decrease in the volume of amniotic fluid can be a sign of fetal distress. A systematic review of trials comparing two methods of testing for amniotic fluid levels recommends the single deepest vertical pocket (SDVP) method over the amniotic fluid index (AFI) method. The AFI method indicated low amniotic levels more often, but without satisfactorily identifying fetal distress, which resulted in more frequent unnecessary induced deliveries.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/a">Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome</a><o:p></o:p></span></p> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><em><b><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Alternative Therapies</span></b></em><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family: "Times New Roman";color:#34758D'><o:p></o:p></span></b></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Herbal remedy may help acute respiratory infections</span></strong><b><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'><br> </span></b><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>There is weak evidence to suggest that Pelargonium sidoides extract EPs(R) 7630, also known as Umckaloabo(R), may be effective in alleviating the symptoms of acute respiratory tract infections such as bronchitis and the common cold. These results are of particular interest given increasing antibiotic resistance and the over-prescribing of antibiotics for these types of infections, which are most commonly due to a virus and not bacteria.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/f">Pelargonium sidoides extract for acute respiratory tract infections</a><o:p></o:p></span></p> <p><strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Oxygen therapy for migraine and cluster headaches</span></strong><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'><br> Hyperbaric oxygen therapy (HBOT) is the therapeutic administration of 100% oxygen at increased environmental pressures, while for normobaric oxygen therapy (NBOT) it is administered at normal pressure. A review of studies showed that while HBOT may help people get rid of their migraines, the availability and delivery of the treatment were challenging. It is possible that NBOT may alleviate cluster headaches. Neither oxygen therapy helped to prevent migraines or cluster headaches.<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/7">Normobaric and hyperbaric oxygen therapy for migraine and cluster headache</a><o:p></o:p></span></p> <div style='mso-element:para-border-div;border:none;border-bottom:dotted #FAA21B 1.0pt; mso-border-bottom-alt:dotted #FAA21B .75pt;padding:0in 0in 0in 0in'> <p class=MsoNormal style='margin-top:.3in;mso-outline-level:2;border:none; mso-border-bottom-alt:dotted #FAA21B .75pt;padding:0in;mso-padding-alt: 0in 0in 0in 0in'><strong><span style='font-family:"Arial","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#FAA21B;mso-font-kerning: 18.0pt'>What s Ahead</span></strong><b><span style='font-family:"Arial","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#FAA21B;mso-font-kerning: 18.0pt'><o:p></o:p></span></b></p> </div> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><strong><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Lost in Knowledge Transfer? Finding our Way Together </span></strong><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family: "Times New Roman";color:#34758D'><br> <strong><span style='font-family:"Arial","sans-serif"'>Health Research Transfer Network of Alberta Conference</span></strong><o:p></o:p></span></b></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>September 28 - 30, 2008<br> Banff, Alberta<br> Early-bird registration deadline:&nbsp;August 28<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/v">www.ahfmr.ab.ca/rtna/conference/</a> <o:p></o:p></span></p> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><strong><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Knowledge Management in Public Health: Exploring Culture, Content, Process and Technology</span></strong><b><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'><o:p></o:p></span></b></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>The National Collaborating Centre for Methods and Tools<br> November 3 - 4, 2008<br> Hamilton, Ontario<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/e">www.nccmt.ca/events/nccmt_events-eng.html</a><o:p></o:p></span></p> <h3><strong><span style='font-family:"Arial","sans-serif";mso-fareast-font-family: "Times New Roman"'>CCNC co-sponsored Events</span></strong><span style='font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></h3> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><strong><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>All About Evidence</span></strong><b><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'><o:p></o:p></span></b></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>Using Cochrane Systematic Reviews and Health Technology Assessments in Healthcare Practice<br> September 24-25, 2008<br> St. John s, NL<br> Web site: <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/s">www.nlcahr.mun.ca/news/e_bulletin/e-bulletin_July_24_2008.pdf</a><o:p></o:p></span></p> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><strong><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>Unravelling the Literature: Understanding Evidence Based Research and How it Can Improve Your Practice</span></strong><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family: "Times New Roman";color:#34758D'><o:p></o:p></span></b></p> <p><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'>October 25, 2008<br> Niagara College School of Dental Hygiene, Ontario<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/g">www.niagaracollege.ca/dentalevent/</a><o:p></o:p></span></p> <p class=MsoNormal style='margin-top:19.2pt;margin-right:0in;margin-bottom: 2.4pt;margin-left:0in;mso-outline-level:3'><b><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:#34758D'>&nbsp;<o:p></o:p></span></b></p> </td> <td width=163 valign=top style='width:122.25pt;background:#BCC7AD; padding:0in 0in 0in 0in' id=rightContent> <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;mso-cellspacing:0in;background:#BCC7AD; mso-yfti-tbllook:1184;mso-padding-alt:3.75pt 3.75pt 3.75pt 3.75pt'> <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> <td style='background:#85976E;padding:3.75pt 3.75pt 3.75pt 3.75pt'> <p class=MsoNormal style='mso-outline-level:2;background:#85976E'><b><span style='font-size:10.0pt;mso-fareast-font-family:"Times New Roman"; color:white;text-transform:uppercase;mso-font-kerning:18.0pt'>7<sup style='text-transform:lowercase'>th</sup> Cochrane Symposium: Wave to the Future<o:p></o:p></span></b></p> </td> </tr> <tr style='mso-yfti-irow:1'> <td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'> <div> <p><span style='font-size:8.5pt'>March 11-12, 2009<br> Halifax, NS<o:p></o:p></span></p> </div> </td> </tr> <tr style='mso-yfti-irow:2'> <td style='background:#85976E;padding:3.75pt 3.75pt 3.75pt 3.75pt'> <p class=MsoNormal style='mso-outline-level:2;background:#85976E'><b><span style='font-size:10.0pt;mso-fareast-font-family:"Times New Roman"; color:white;text-transform:uppercase;mso-font-kerning:18.0pt'>3rd most accessed review in 2007<o:p></o:p></span></b></p> </td> </tr> <tr style='mso-yfti-irow:3;mso-yfti-lastrow:yes'> <td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'> <div> <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt: auto;mso-outline-level:4'><b><span style='font-size:9.0pt;mso-fareast-font-family: "Times New Roman"'>Beta-blockers not the best first-line choice for hypertension <o:p></o:p></span></b></p> <p><span style='font-size:8.5pt'>A Cochrane review recommends that beta-blockers should not be used as the first-line of defense in treating patients with high blood pressure. The reviewers found that beta-blockers were not as good at decreasing mortality and morbidity as other classes of drugs: thiazides, calcium channel blockers and renin angiotensin system inhibitors. In fact, they were even associated with worse outcomes relative to the other classes of drugs.<o:p></o:p></span></p> <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt: auto;mso-outline-level:4'><b><span style='font-size:9.0pt;mso-fareast-font-family: "Times New Roman"'><a href="http://cochrane.cmail4.com/l/481431/6i1diyml/9">Beta-blockers for hypertension</a><o:p></o:p></span></b></p> </div> </td> </tr> </table> <p><span style='font-family:"Arial","sans-serif"'>&nbsp;<o:p></o:p></span></p> <div style='mso-element:para-border-div;border:none;border-top:solid #85976E 1.0pt; mso-border-top-alt:solid #85976E .75pt;padding:0in 0in 0in 0in'> <p style='border:none;mso-border-top-alt:solid #85976E .75pt;padding:0in; mso-padding-alt:0in 0in 0in 0in'><span style='font-family:"Arial","sans-serif"'>&nbsp;<o:p></o:p></span></p> </div> <p><em><span style='font-family:"Arial","sans-serif"'>Pass it on! Click </span></em><strong><i><span style='font-family:"Arial","sans-serif"'><a href="http://www.forwardtomyfriend.com/4dbe/263c6687648154c7c94d5de2eb09ca4e/">here</a></span></i></strong><em><span style='font-family:"Arial","sans-serif"'> to forward to a friend or colleague.</span></em><span style='font-family:"Arial","sans-serif"'> <o:p></o:p></span></p> <div style='mso-element:para-border-div;border:none;border-bottom:solid #85976E 1.0pt; mso-border-bottom-alt:solid #85976E .75pt;padding:0in 0in 0in 0in'> <p style='border:none;mso-border-bottom-alt:solid #85976E .75pt;padding: 0in;mso-padding-alt:0in 0in 0in 0in'><span style='font-family:"Arial","sans-serif"'>&nbsp;<o:p></o:p></span></p> </div> </td> </tr> <tr style='mso-yfti-irow:2;mso-yfti-lastrow:yes'> <td colspan=2 style='padding:0in 0in 0in 0in' id=footer> <div align=center> <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;mso-cellspacing:0in;mso-yfti-tbllook: 1184;mso-padding-alt:0in 0in 0in 0in'> <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> <td valign=top style='background:#85976E;padding:0in 0in 0in 0in'> <p class=MsoNormal><span style='mso-fareast-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p> </td> <td colspan=2 valign=top style='background:#85976E;padding:0in 0in 0in 0in'> <p align=center style='text-align:center'><span style='font-size:9.0pt; color:white'>The Canadian Cochrane Network and Centre is one of 12 independent, not-for-profit <br> Cochrane Centres worldwide. Over 1200 people in Canada contribute to the Cochrane Collaboration<br> and Cochrane systematic reviews. <br> CCNC is funded by the Canadian Institutes of Health Research and the Canadian Agency for<br> Drugs and Technologies in Health. <o:p></o:p></span></p> <div style='border:none;border-bottom:dotted white 1.0pt;mso-border-bottom-alt: dotted white .75pt;padding:0in 0in 0in 0in'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;mso-fareast-font-family:"Times New Roman"; color:white'>&nbsp;<o:p></o:p></span></p> </div> </td> <td valign=top style='background:#85976E;padding:0in 0in 0in 0in'> <p class=MsoNormal><span style='mso-fareast-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:1;mso-yfti-lastrow:yes'> <td width=17 valign=bottom style='width:12.75pt;background:#85976E; padding:0in 0in 0in 0in'> <p class=MsoNormal><span style='mso-fareast-font-family:"Times New Roman"'><img border=0 width=17 height=57 id="_x0000_i1026" src="http://cochrane.cmail4.com/email/481431/cochranecubiclefugitivecom/images/roundedcorner_lb.gif"><o:p></o:p></span></p> </td> <td width=283 valign=top style='width:212.25pt;background:#85976E; padding:0in 0in 0in 0in'> <p><span style='font-size:9.0pt;color:white'>Relay Cochrane! is published four times <br> a year  <a href="http://www.forwardtomyfriend.com/4dbe/263c6687648154c7c94d5de2eb09ca4e/"><strong><i>pass it on!</i></strong></a><o:p></o:p></span></p> <p><span style='font-size:9.0pt;color:white'>To subscribe, email <a href="mailto:cochrane@uottawa.ca">cochrane@uottawa.ca</a>.<o:p></o:p></span></p> </td> <td width=283 valign=top style='width:212.25pt;background:#85976E; padding:0in 0in 0in 0in'> <p align=right style='text-align:right'><strong><span style='font-size: 9.0pt;color:white'>Canadian Cochrane Network and Centre</span></strong><span style='font-size:9.0pt;color:white'><br> 1 Stewart St (229)<br> Ottawa, ON, Canada K1N 6N5<br> <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/w">www.ccnc.cochrane.org</a><o:p></o:p></span></p> </td> <td width=17 valign=bottom style='width:12.75pt;background:#85976E; padding:0in 0in 0in 0in'> <p class=MsoNormal align=right style='text-align:right'><span style='mso-fareast-font-family:"Times New Roman"'><img border=0 width=17 height=57 id="_x0000_i1027" src="http://cochrane.cmail4.com/email/481431/cochranecubiclefugitivecom/images/roundedcorner_rb.gif"><o:p></o:p></span></p> </td> </tr> <![if !supportMisalignedColumns]> <tr height=0> <td width=17 style='border:none'></td> <td width=283 style='border:none'></td> <td width=283 style='border:none'></td> <td width=17 style='border:none'></td> </tr> <![endif]> </table> </div> </td> </tr> </table> </td> </tr> </table> </div> <p align=center style='text-align:center'><span style='font-size:8.5pt'>This email was sent to <a href="mailto:lmcgover@UOTTAWA.CA">lmcgover@UOTTAWA.CA</a>. Click here to instantly <a href="http://cochrane.cmail4.com/u/481431/6i1diyml/">unsubscribe</a>.<br> Design by <a href="http://cochrane.cmail4.com/l/481431/6i1diyml/6t">Cubicle Fugitive</a><o:p></o:p></span></p> </div> <p class=MsoNormal><span style='mso-fareast-font-family:"Times New Roman"'><img border=0 width=1 height=1 id="_x0000_i1028" src="http://cochrane.cmail4.com/o/481431/6i1diyml/o.gif" style='border-bottom-width: 0in;border-left-width:0in;border-right-width:0in;border-top-width:0in; height:1px;margin-bottom:0in;margin-left:0in;margin-right:0in;margin-top:0in; padding-bottom:0in;padding-left:0in;padding-right:0in;padding-top:0in; width:1px'><o:p></o:p></span></p> </div> </body> </html>